We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
Cap. Flow
-$695M
Cap. Flow %
-0.92%
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$840M
2
DIS icon
Walt Disney
DIS
+$492M
3
BA icon
Boeing
BA
+$492M
4
SBUX icon
Starbucks
SBUX
+$276M
5
SLB icon
SLB Ltd
SLB
+$216M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Consumer Discretionary 16.31%
3 Communication Services 13.43%
4 Healthcare 12.88%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEIC icon
26
SEI Investments
SEIC
$12.6B
$854M 1.13%
14,868,214
-868,061
-6% -$47.4M
FDS icon
27
Factset
FDS
$10.2B
$832M 1.1%
2,502,880
-171,230
-6% -$56.6M
ISRG icon
28
Intuitive Surgical
ISRG
$134B
$747M 0.99%
2,739,624
-189,228
-6% -$47M
YUM icon
29
Yum! Brands
YUM
$41.1B
$712M 0.94%
6,554,250
-449,476
-6% -$45.9M
BMY icon
30
Bristol-Myers Squibb
BMY
$132B
$711M 0.94%
11,464,109
-1,922,942
-14% -$118M
T icon
31
AT&T
T
$163B
$706M 0.93%
32,480,988
+698,994
+2% +$15.1M
SLB icon
32
SLB Ltd
SLB
$75B
$688M 0.91%
31,510,780
+11,455,559
+57% +$216M
YUMC icon
33
Yum China
YUMC
$16.3B
$581M 0.77%
10,177,205
-637,820
-6% -$35.8M
NVO
34
Novo Nordisk
NVO
$209B
$477M 0.63%
13,649,312
-909,830
-6% -$31.4M
ADP icon
35
Automatic Data Processing
ADP
$108B
$414M 0.55%
2,352,427
-103,865
-4% -$17.1M
GLW icon
36
Corning
GLW
$143B
$338M 0.45%
9,397,546
-563,888
-6% -$20M
DHR icon
37
Danaher
DHR
$144B
$327M 0.43%
1,659,509
-38,469
-2% -$7.71M
MA icon
38
Mastercard
MA
$493B
$296M 0.39%
829,071
+19,089
+2% +$6.35M
IQV icon
39
IQVIA
IQV
$39.3B
$292M 0.39%
1,630,976
+29,211
+2% +$4.92M
ROP icon
40
Roper Technologies
ROP
$39.8B
$279M 0.37%
647,768
+13,570
+2% +$5.57M
UNH icon
41
UnitedHealth
UNH
$370B
$274M 0.36%
781,093
+40,023
+5% +$13.4M
LIN icon
42
Linde
LIN
$226B
$268M 0.35%
1,017,682
+22,364
+2% +$5.49M
EL icon
43
Estee Lauder
EL
$32B
$243M 0.32%
912,452
+12,599
+1% +$3.03M
ACN icon
44
Accenture
ACN
$108B
$232M 0.31%
889,812
+57,903
+7% +$13.9M
PTON icon
45
Peloton Interactive
PTON
$2.49B
$223M 0.29%
1,468,439
+30,175
+2% +$3.68M
SPGI icon
46
S&P Global
SPGI
$120B
$219M 0.29%
665,864
+10,351
+2% +$3.49M
HD icon
47
Home Depot
HD
$355B
$197M 0.26%
742,544
+220,686
+42% +$60.7M
DBX icon
48
Dropbox
DBX
$8.12B
$187M 0.25%
8,414,762
-16,124
-0.2% -$328K
VRSN icon
49
VeriSign
VRSN
$26.6B
$187M 0.25%
862,271
+17,870
+2% +$3.66M
COST icon
50
Costco
COST
$420B
$185M 0.24%
491,650
+71,303
+17% +$26.6M

Similar funds

Loomis, Sayles & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
  • Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
  • Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
  • Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
  • Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.